Skip to content
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Visit
Home
(current)
Specialties
Hematology
Oncology
Musculoskeletal Disorder
Rare Disease
Metabolic Disorder
Cardiovascular Disease
Ophthalmology
Neurology
Infectious Disease
View all Specialties
Technologies
Cell Therapy
MSC
iPSC
Gene Therapy
Genome Editing
Extracellular Vesicles
CAR-T Therapy
TCR Therapy
Tissue-Engineering & Biomaterials
View all Technologies
Topics
Treatment
Immuno-Oncology
Trial Updates
Perspectives
Manufacturing
COVID-19
View all Topics
Conferences
TCT 2022
Meeting on the Med 2022
ICLE 2022
Advanced Therapies Week 2022
TERMIS 2021
ESGCT 2021
Meeting on the Mesa 2021
Advanced Therapies 2021
CAR-TCR Global 2021
View all Conferences
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Lymphoma
1:58
LMY-920 in non-Hodgkin lymphoma
Jeff Liter
• 27 Jan 2022
5:09
Mechanisms of resistance to CAR T-cell therapies
John Rossi
• 26 Aug 2021
4:24
Chimeric engulfment receptor (CER) T-cell therapy
John Rossi
• 26 Jul 2021
2:17
Liquid vs solid tumor strategies in cell therapy
Kanya Rajangam
• 13 Oct 2021
1:05
NKX019 in B-cell malignancies
Kanya Rajangam
• 13 Oct 2021
4:33
ISCT 2021 highlights: therapeutic deception, global regulation & CAR-T
Aaron Levine
• 28 May 2021
6:10
Challenges of CAR T-cell therapy for AML: is CD38 the answer?
Lei Yu
• 3 Jun 2021
3:07
Horizon scanning in anti-CD19 CAR T-cell therapy
Marco Alessandrini
• 20 May 2021
1:33
Improving education in cell therapy
Emanuele Ostuni
• 12 Apr 2021
3:05
Targetting cancer with allogeneic NK cell therapies
James Trager
• 10 Mar 2021
2:09
CAR-NKs for B cell malignancies
James Trager
• 10 Mar 2021
2:13
CAR-T in DLBCL: 4-year follow-up data from ZUMA-1
Anna Sureda
• 9 Feb 2021
4:31
Novel strategies to optimize CAR T-cell therapy
Arnon Nagler
• 1 Feb 2021
2:02
Infectious complications after CAR T-cell therapy
Joshua Hill
• 10 Feb 2021
3:19
Infection prevention in patients receiving CAR T-cells
Joshua Hill
• 10 Feb 2021
3:30
Second CD19-targeted CAR T-cell infusion for R/R B-cell malignancies
Jordan Gauthier
• 28 Jan 2021
1
2
3
Next
